Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy.
Kanemaru Y, Natsumeda M, Okada M, Saito R, Kobayashi D, Eda T, Watanabe J, Saito S, Tsukamoto Y, Oishi M, Saito H, Nagahashi M, Sasaki T, Hashizume R, Aoyama H, Wakai T, Kakita A, Fujii Y.
Kanemaru Y, et al. Among authors: saito r, saito s, saito h.
Acta Neuropathol Commun. 2019 Jul 25;7(1):119. doi: 10.1186/s40478-019-0774-7.
Acta Neuropathol Commun. 2019.
PMID: 31345255
Free PMC article.